Perceptive Advisors - MERRIMACK PHARMACEUTICALS IN ownership

Quarter-by-quarter ownership
Perceptive Advisors ownership history of MERRIMACK PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2016$200,000
-35.7%
48,9100.0%0.01%
-30.0%
Q3 2016$311,000
+15.2%
48,910
-2.2%
0.02%
+5.3%
Q2 2016$270,000
-35.6%
50,0000.0%0.02%
-48.6%
Q1 2016$419,000
+6.1%
50,0000.0%0.04%
+27.6%
Q4 2015$395,00050,0000.03%
Other shareholders
MERRIMACK PHARMACEUTICALS IN shareholders Q3 2023
NameSharesValueWeighting ↓
GARRISON BRADFORD & ASSOCIATES INC 98,001$661,0000.71%
Tekla Capital Management LLC 537,600$3,618,0000.49%
CAMBRIDGE TRUST CO 239,003$1,611,0000.17%
FARALLON CAPITAL MANAGEMENT LLC 1,067,538$7,185,0000.14%
Asset Management Group, Inc. 29,453$199,0000.14%
Magnetar Financial LLC 754,837$5,080,0000.11%
Trellus Management Company, LLC 11,000$74,0000.09%
JAMISON EATON & WOOD INC /NJ 42,042$283,0000.08%
WESTFIELD CAPITAL MANAGEMENT CO LP 1,491,850$10,055,0000.07%
NORTH AMERICAN MANAGEMENT CORP 45,000$303,0000.06%
View complete list of MERRIMACK PHARMACEUTICALS IN shareholders